Maternus-Kliniken Aktiengesellschaft (MAK.DE)
EUR 1.49
(-2.61%)
EUR 1.49
(-2.61%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 | 53.96 Million EUR | -59.59% |
| 2022 | 133.52 Million EUR | -3.56% |
| 2021 | 138.45 Million EUR | -8.99% |
| 2020 | 152.12 Million EUR | 68.92% |
| 2019 | 90.06 Million EUR | -7.85% |
| 2018 | 97.72 Million EUR | 33.47% |
| 2017 | 73.22 Million EUR | -0.79% |
| 2016 | 73.8 Million EUR | -3.73% |
| 2015 | 76.66 Million EUR | 88.21% |
| 2014 | 40.73 Million EUR | 31.13% |
| 2013 | 31.06 Million EUR | -59.77% |
| 2012 | 77.22 Million EUR | 0.0% |
| 2011 | - EUR | 0.0% |
| 2010 | - EUR | 0.0% |
| 2009 | - EUR | -100.0% |
| 2008 | 50.86 Million EUR | 197.13% |
| 2007 | 17.11 Million EUR | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 Q2 | 127.1 Million EUR | 0.0% |
| 2023 Q2 | 130.45 Million EUR | 0.0% |
| 2023 Q3 | 105.88 Million EUR | -18.84% |
| 2023 FY | 53.96 Million EUR | -59.59% |
| 2023 Q4 | 105.88 Million EUR | 0.0% |
| 2023 Q1 | - EUR | -100.0% |
| 2022 Q1 | - EUR | -100.0% |
| 2022 Q4 | 54.23 Million EUR | -51.32% |
| 2022 Q3 | 111.4 Million EUR | -18.32% |
| 2022 Q2 | 136.38 Million EUR | 0.0% |
| 2022 FY | 133.52 Million EUR | -3.56% |
| 2021 Q4 | 54.45 Million EUR | -53.17% |
| 2021 Q3 | 116.27 Million EUR | -22.59% |
| 2021 FY | 138.45 Million EUR | -8.99% |
| 2021 Q1 | - EUR | -100.0% |
| 2021 Q2 | 150.19 Million EUR | 0.0% |
| 2020 Q3 | 129.8 Million EUR | -8.46% |
| 2020 Q1 | - EUR | -100.0% |
| 2020 Q2 | 141.79 Million EUR | 0.0% |
| 2020 FY | 152.12 Million EUR | 68.92% |
| 2020 Q4 | 54.63 Million EUR | -57.91% |
| 2019 Q3 | 67.7 Million EUR | -49.75% |
| 2019 FY | 90.06 Million EUR | -7.85% |
| 2019 Q2 | 134.73 Million EUR | 0.0% |
| 2019 Q1 | - EUR | -100.0% |
| 2019 Q4 | 1000.00 EUR | -100.0% |
| 2018 Q4 | 75.67 Million EUR | 0.0% |
| 2018 Q3 | 75.67 Million EUR | 4.42% |
| 2018 Q2 | 72.46 Million EUR | 0.0% |
| 2018 FY | 97.72 Million EUR | 33.47% |
| 2018 Q1 | - EUR | -100.0% |
| 2017 Q3 | 51.16 Million EUR | -29.91% |
| 2017 Q4 | 51.16 Million EUR | 0.0% |
| 2017 Q2 | 72.99 Million EUR | 0.0% |
| 2017 Q1 | - EUR | -100.0% |
| 2017 FY | 73.22 Million EUR | -0.79% |
| 2016 Q4 | 51.74 Million EUR | 0.0% |
| 2016 FY | 73.8 Million EUR | -3.73% |
| 2016 Q3 | 51.74 Million EUR | -31.14% |
| 2016 Q2 | 75.14 Million EUR | 0.0% |
| 2016 Q1 | - EUR | -100.0% |
| 2015 Q2 | 79.59 Million EUR | 98.28% |
| 2015 Q3 | 77.36 Million EUR | -2.8% |
| 2015 Q4 | 76.66 Million EUR | -0.92% |
| 2015 FY | 76.66 Million EUR | 88.21% |
| 2015 Q1 | 40.14 Million EUR | -1.44% |
| 2014 Q4 | 40.73 Million EUR | 36.18% |
| 2014 Q1 | - EUR | -100.0% |
| 2014 FY | 40.73 Million EUR | 31.13% |
| 2014 Q2 | 30.3 Million EUR | 0.0% |
| 2014 Q3 | 29.91 Million EUR | -1.3% |
| 2013 Q3 | 73.78 Million EUR | -2.65% |
| 2013 FY | 31.06 Million EUR | -59.77% |
| 2013 Q2 | 75.78 Million EUR | -1.16% |
| 2013 Q1 | 76.67 Million EUR | -0.7% |
| 2013 Q4 | 31.06 Million EUR | -57.9% |
| 2012 Q2 | - EUR | 0.0% |
| 2012 Q1 | - EUR | -100.0% |
| 2012 FY | 77.22 Million EUR | 0.0% |
| 2012 Q4 | 77.22 Million EUR | 88.24% |
| 2012 Q3 | 41.02 Million EUR | 0.0% |
| 2011 FY | - EUR | 0.0% |
| 2011 Q3 | - EUR | 0.0% |
| 2011 Q2 | - EUR | 0.0% |
| 2011 Q4 | 76.57 Million EUR | 0.0% |
| 2011 Q1 | - EUR | 0.0% |
| 2010 Q4 | - EUR | 0.0% |
| 2010 FY | - EUR | 0.0% |
| 2009 FY | - EUR | -100.0% |
| 2008 FY | 50.86 Million EUR | 197.13% |
| 2007 FY | 17.11 Million EUR | 0.0% |
| Name | Long Term Debt | Long Term Debt Difference |
|---|---|---|
| Fresenius Medical Care AG & Co. KGaA | 10.48 Billion EUR | 99.486% |
| Fresenius SE & Co. KGaA | 13.24 Billion EUR | 99.593% |
| LIMES Schlosskliniken AG | 10.09 Million EUR | -434.814% |
| M1 Kliniken AG | 1.87 Million EUR | -2778.027% |
| MEDICLIN Aktiengesellschaft | 66.41 Million EUR | 18.753% |
| RHÖN-KLINIKUM Aktiengesellschaft | 141.77 Million EUR | 61.938% |
| VITA 34 AG | 3.38 Million EUR | -1493.239% |